Emerging Company and Venture Capital

Emerging Company and Venture Capital

Helping clients launch their businesses and transform their innovative ideas into successful companies.

Key Contacts

Meet Our Team

Areas of Focus

Expand All Collapse All

WilmerHale Launch

A resource for entrepreneurs and founders of startups in various stages of growth, WilmerHale Launch is your source for answers to the questions that impact you every day. We provide the tools and information you need to build your knowledge and position your startup for success.

2018 Venture Capital Report—An In-Depth US Venture Capital Market Review and Outlook



  • Representing investors such as Advanced Technology Ventures, Atlas Venture, Flagship Pioneering, Matrix Partners, New Leaf Ventures, North Bridge Venture Partners, Spark Capital, Sofinnova Ventures and many others in venture financings.
  • Represented Stash, a financial technology platform revolutionizing investment and financial literacy across the US, in its $40 million in Series C and $37.5 million Series D financings.
  • Represented Generation Bio, a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit, in a $100 million Series B financing. Proceeds will be used to move its first two therapeutic candidates through Investigational New Drug enabling studies. We also previously advised the company in its $25 million Series A financing. 
  • Represented Andela—a startup that identifies the most talented individuals in Africa, shapes them into world-class developers, and pairs them with the world’s leading tech companies—in its $40 million Series C. The round was led by the Chan Zuckerberg Initiative, a for-profit entity formed by Facebook CEO Mark Zuckerberg and his wife, Priscilla Chan. We also represented the company in its $24 million Series B funding round.
  • Represented Visterra, a clinical-stage biotechnology company that uses its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody-based biological medicines against them, in its $46.7 million Series C financing round, including a new extension totaling $23.6 million. 
  • Represented 1366 Technologies, a developer of manufacturing solutions for silicon cell manufacturers, in its $9 million in Series D funding from strategic partners and return investors. The new funding will be used to further their scaling plans and brings them closer to realizing their vision for the future where solar energy displaces coal as the cheapest fuel source on the planet. 
  • Represented Fulcrum Therapeutics, a company focused on unlocking gene control mechanisms to develop small molecule therapies, in its launch and its $55 million Series A financing (and Series A extension with Google Ventures) and $80 million Series B financing in support of its lead programs in fragile x syndrome and fascioscapularhumeral muscular dystrophy.
  • Represented UnifyID, a company leading the development of an implicit authentication platform that requires zero conscious user actions, in its $20 million Series A led by New Enterprise Associates. Andreessen Horowitz, Stanford-StartX and Accomplice Ventures previously invested in the company’s seed round, bringing the total invested to $23.4 million. This latest round of funding will be used to grow the team to expand enterprise trials, accelerate research, and maintain the company’s position as the leader in implicit authentication and behavioral biometrics.
  • Represented UNTUCKit, a leading direct-to-consumer apparel brand, in a $30 million fundraising round led by Kleiner Perkins. UNTUCKit will use this funding to open 15 new stores, expand its women’s line and launch children’s apparel. According to sources, the deal values the company at around $200 million. 
  • Represented Hyalax Orthopaedics, a medical device company advancing new products that feature HYALEX™ technology, a synthetic polymer that mimics cartilage, in a $16 million Series A financing. 
  • Represented Trevi Therapeutics, a late-stage clinical development company focused on treatments for chronic itch, in its $50 million Series C financing led by New Enterprise Associates. The company plans to use the proceeds from the financing to advance the development of Nalbuphine ER, a drug with a dual agonist/antagonist mechanism of action uniquely suited to treating itch associated in various dermatologic, metabolic, hematologic and neuropathic conditions.
  • Represented Bark & Co., the company behind BarkBox, in raising $60 million in new funding.
  • Represented Civis Analytics, a leader in data science software and services, in its $22 million Series A financing led by Drive Capital with participation from Verizon Ventures, WPP and Eric Schmidt, the Executive Chairman of Alphabet, Inc. 
  • Represented Cape Analytics in its $14 million Series A financing, with participation from Formation 8, XL Innovate, Data Collective, Lux Capital, Khosla Ventures, Promus Ventures and Montage Ventures. The company uses computer vision and machine learning to improve automated property underwriting for insurance companies.
  • Represented The Muse, an online career resource targeting millennials, with more than 50 million users per year, in a $16 million Series B led by Icon Ventures. With this fresh capital infusion, in addition to expanding into new markets, The Muse will further scale the business across employer product suites, career advice tools, and the company's recently launched professional development platform.
  • Represented Kite Hill, a brand that makes plant-based cheeses, yogurts, cream cheese–style spreads and other dairy-analogue products, in an $18 million funding round.


  • Award Text

    Recognized as a Top Firm in the Nation for Startups & Emerging Companies

    Chambers USA


  • Award Text

    Recommended for Venture Capital and Emerging Companies

    The Legal 500 United States


  • Award Text

    Named a Leading Law Firm for Venture Capital Law

    U.S. News - Best Lawyers®


  • American Lawyer – The 2017 Corporate Scorecard report ranked WilmerHale among the top five law firms handling IPOs for issuers based on the number of transactions in 2016.
  • Best Lawyers in America – Recognized 114 WilmerHale partners for 2019, naming nine as “Lawyers of the Year,” including Jay Bothwick as Boston Mergers and Acquisitions Law Lawyer of the Year and David Westenberg as Boston Information Technology Law Lawyer of the Year.
  • Chambers USA: America’s Leading Lawyers for Business – Named our corporate practice among the best in 2012–2018, with sources saying that WilmerHale provides “excellent service and quality advice and representation” and is very knowledgeable with a deep wealth of information on matters impacting rapidly growing venture-backed startups. The 2018 edition of Chambers USA also ranked WilmerHale in the following regions and practices: Massachusetts and Washington DC for Corporate/M&A; nationwide for Startups & Emerging Companies; and Massachusetts for Private Equity: Venture Capital Investment and Technology.
  • Corporate Board Member – In 2014, 2016 and 2018, WilmerHale was named to Top National Corporate Law Firms list, a comprehensive ranking of the top 25 firms in the nation. Results are based on law firm surveys and feedback from thousands of directors and general counsel.
  • Lake Whillans – The Life Sciences Law Firm Index included WilmerHale among the top three best life sciences law firms (2016, 2017), as the top firm for startup work (2017), among the top 10 deal firms (2017), as one of the top two patent law firms (2016) and among the top 10 firms for thought leadership (2016).
  • Law360 – Named WilmerHale a Technology Practice Group of the Year for 2016 and 2017, an award recognizing the firm’s key role in the significant matters that made headlines and changed the legal landscape within the past year. 
  • Super Lawyers – Our corporate lawyers are consistently recognized as “Super Lawyers” and “Rising Stars” in multiple jurisdictions.
  • The Legal 500 United States – Recommended WilmerHales mergers and acquisitions practice in the areas of antitrust, commercial deals and contracts, M&A middle-market, and venture capital and emerging companies in their 2010–2017 editions. 
  • U.S. News - Best Lawyers® – In the 2010–2017 “Best Law Firms” rankings, our corporate law, mergers and acquisitions, and venture capital law practices were ranked in the first tier nationally and in Boston, along with our corporate law practice also being ranked in the first-tier in New York and Washington DC. Our technology law practice was also ranked in the first-tier in Boston and in the second-tier nationally.

Insights & News